Centessa Pharmaceuticals plc (CNTA)
Jun 24, 2026 - CNTA was delisted (reason: acquired by LLY)
40.50
+0.32 (0.80%)
Inactive · Last trade price on Jun 23, 2026
Centessa Pharmaceuticals Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Centessa Pharmaceuticals stock had an average target of $44.17, with a low estimate of $38 and a high estimate of $62.
Price Target: $44.17 (+9.06%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Apr 20, 2026.
Analyst Ratings
The average analyst rating for Centessa Pharmaceuticals stock from 12 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 13 | 8 | 3 | 3 | 3 |
| Buy | 3 | 3 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 4 | 9 | 9 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 16 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | May 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Apr 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Downgrades $42 | Hold | Downgrades | $42 | +3.70% | Apr 20, 2026 |
| Truist Financial | Truist Financial | Hold Downgrades $38 | Hold | Downgrades | $38 | -6.17% | Apr 13, 2026 |
| Guggenheim | Guggenheim | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Apr 1, 2026 |
Financial Forecast
Revenue This Year
n/a
from 15.00M
Decreased by -100.00%
Revenue Next Year
28.57M
EPS This Year
-1.56
from -1.46
EPS Next Year
-1.78
from -1.56
EPS and Forward PE are based on non-GAAP adjusted numbers.